Skip to content

GNTA GENENTA SCIENCE S P A

Follow

SPONSORED ADS (ADR), issuer CIK 1838716

6 managers (6 13F filers) reported a position in GNTA shares at 2025-06-30, 537,320 shares in all. 1 filer opened a position and 1 filer sold out during the quarter.

Managers
6
13F filers
6
New
1
Added
1
Reduced
1
Sold out
1
Shares held by filers
537,320

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

  • Nuzzo Marco (group Marco Nuzzo)
    5,543,910 shares, 11.5% in a 13D/A as of 2026-05-29,0001493152-26-045500
    Accepted , ingested

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q2 2025

Filers in the available 13F reports with a share position at 2025-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
AlTi Global, Inc.in group AlTi Global, Inc.200,288$791K0.02%013F-HRTimelineGroup
Allianz SEin group Allianz SE234,050$713K0.02%+50013F-HRTimelineGroup
ALGEBRIS (UK) LTDin group ALGEBRIS (UK) LTD100,000$310K0.05%013F-HRTimelineGroup
MORGAN STANLEYin group MORGAN STANLEY2,000$6.09K<0.01%-1,40013F-HRTimelineGroup
EverSource Wealth Advisors, LLCin group EverSource Wealth Advisors, L…982$2.99K<0.01%new13F-HRTimelineGroup
CONCOURSE FINANCIAL GROUP SECURITIES, I…0$0013F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios.

Events

  • Nuzzo Marco and 10 other reporting persons reported 5,543,910 GNTA shares, 11.5% of the class, as of 2026-05-29, in a 13D/A filed 2026-10-02. 0001493152-26-045500

    Accepted , ingested